Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.7
4.6
Journals
Pharmaceuticals
Special Issues
Drug Delivery Systems for Local Anesthetics
share announcement

Drug Delivery Systems for Local Anesthetics

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: 22 August 2024 | Viewed by 1768

Special Issue Editors

Prof. Dr. Michelle Franz-Montan

E-Mail Website
Guest Editor
Department of Biosciences, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba 13083-970, SP, Brazil
Interests: topical anesthesia; oral cavity; oral mucosa; dental anesthesia; drug delivery; mucoadhesive system; dentistry
Special Issues, Collections and Topics in MDPI journals
Dr. Camila Batista Da Silva

E-Mail Website
Guest Editor
Department of Biosciences-Pharmacology, Anesthesiology & Therapeutics Area, Piracicaba Dental School, University of Campinas, Av. Limeira, nº 901, Bairro Areião, Piracicaba 13414-903, SP, Brazil
Interests: dentistry; local anesthetic; medical emergency; anxiety

Special Issue Information

Dear Colleagues,

Local anesthetics (LAs) are among the most useful drugs in anesthesiology practice and pain management, as they cause a temporary loss of pain by inhibiting the transmission of nerve impulses. Thus, they have been widely used in clinical practice. However, the applications of anesthetics are greatly limited due to their neurotoxicity and short half-lives. To overcome these barriers, numerous drug delivery systems (DDSs) have been designed to encapsulate local anesthetic agents so that large doses can be released slowly and provide analgesia over a prolonged period. Formulation approaches to systemically deliver LA include the encapsulation of liposomes, the complexation of cyclodextrins, and associations with biopolymers and other carrier systems. This Special Issue, entitled “Drug Delivery Systems for Local Anesthetics”, considers drug delivery formulations of local anesthetics designed to prolong the anesthetic effect and decrease toxicity.

We invite authors to submit original research articles or review articles outlining innovations pertaining to formulations and techniques for drug delivery of topical and injectable local anesthetics.

Prof. Dr. Michelle Franz-Montan
Dr. Camila Batista Da Silva
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • local anesthetics
  • drug delivery system
  • liposomes
  • biopolymers
  • cyclodextrins
  • polymers
  • micro- and nanoparticles
  • topical formulations

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

14 pages, 2036 KiB  
Article
Polymeric Nanocapsules Loaded with Lidocaine: A Promising Formulation for Topical Dental Anesthesia
by Camila Batista da Silva, Cleiton Pita dos Santos, Luciano Serpe, Jonny Burga Sanchez, Luiz Eduardo Nunes Ferreira, Nathalie Ferreira Silva de Melo, Francisco Carlos Groppo, Leonardo Fernandes Fraceto, Maria Cristina Volpato and Michelle Franz-Montan
Pharmaceuticals 2024, 17(4), 485; https://0-doi-org.brum.beds.ac.uk/10.3390/ph17040485 - 10 Apr 2024
Viewed by 452
Abstract
Lidocaine is the most commonly used local anesthetic worldwide, known for its rapid onset and moderate duration of anesthesia. However, it is short-lived and does not effectively promote effective topical anesthesia in the oral cavity when used alone. Our aim was to investigate [...] Read more.
Lidocaine is the most commonly used local anesthetic worldwide, known for its rapid onset and moderate duration of anesthesia. However, it is short-lived and does not effectively promote effective topical anesthesia in the oral cavity when used alone. Our aim was to investigate whether an approximate 50% encapsulation of lidocaine in poly(ε-caprolactone) nanocapsules (LDC-Nano) would be able to increase its permeation and analgesic efficacy and reduce cytotoxicity. In this study, we characterized LDC-Nano and conducted MTT tests with HaCaT cells to assess their in vitro cytotoxicity. Additionally, in vitro permeation assays across the pig esophageal epithelium and the anesthetic efficacy of the hind paw incision model in rats were performed. Plain lidocaine (LDC) was compared with LDC-Nano and lidocaine hydrochloride plus epinephrine (LDC-Epi). The physicochemical characteristics of LDC-Nano were satisfactory (pH: 8.1 ± 0.21; polydispersity index: 0.08 ± 0.01; mean diameter (nm): 557.8 ± 22.7; and encapsulation efficiency (%): 51.8 ± 1.87) and remained stable for up to 4 months. LDC-Nano presented similar in vitro cytotoxicity to LDC but was higher than LDC-Epi (LD50: LDC = 0.48%; LDC-Nano = 0.47%; and LDC-Epi = 0.58%; p < 0.0001). Encapsulation increased the permeability coefficient about 6.6 times and about 7.5 the steady-state flux of lidocaine across the mucosal epithelium. Both encapsulation and epinephrine improved anesthesia duration, with epinephrine demonstrating superior efficacy (100% of animals were anesthetized up to 100, 30, and 20 min when LDC-Epi, LDC-nano, and LDC were used, respectively). Although LDC-Epi demonstrated superior in vivo anesthetic efficacy, the in vitro permeation and cytotoxicity of LDC-Nano indicate promising avenues for future research, particularly in exploring its potential application as a topical anesthetic in the oral cavity. Full article
(This article belongs to the Special Issue Drug Delivery Systems for Local Anesthetics)
►▼ Show Figures

Figure 1

12 pages, 1944 KiB  
Article
Development of a Dosage form for a Photoswitchable Local Anesthetic Ethercaine
by Alexey Noev, Natalia Morozova, Nikita Suvorov, Yuriy Vasil’ev, Andrei Pankratov and Mikhail Grin
Pharmaceuticals 2023, 16(10), 1398; https://0-doi-org.brum.beds.ac.uk/10.3390/ph16101398 - 02 Oct 2023
Viewed by 1002
Abstract
The toxicity of local anesthetics is a serious problem, given their widespread use. One of the main causes of the side effects of local anesthetics is their non-selectivity of action in the body. A possible way to increase the selectivity of the action [...] Read more.
The toxicity of local anesthetics is a serious problem, given their widespread use. One of the main causes of the side effects of local anesthetics is their non-selectivity of action in the body. A possible way to increase the selectivity of the action of drugs is to use the photopharmacology approach. Previously, we described the light-controlled local anesthetic ethercaine, the biological effect of which can be controlled using light, thereby increasing its selectivity of action. An important limitation of ethercaine was its low solubility in water, limiting the potential of this compound. In this work, we developed a dosage form of ethercaine, which allowed us to increase its solubility from 0.6% to 2% or more. The resulting 1% solution of ethercaine hydrochloride in 4% Kolliphor ELP had high biological activity on the surface anesthesia model, while demonstrating low acute toxicity in mice with intravenous administration (4–5 times less than that of lidocaine). Full article
(This article belongs to the Special Issue Drug Delivery Systems for Local Anesthetics)
►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop